Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

42,576 stories, page 525 of 710

Advanced search

🇺🇸Jul 14Industryelementbiosciences.comTier 1 · Company source

Element Biosciences Prevails in German Patent Case Against Illumina

Element BiosciencesOriginal source

🌍Jul 14Researchpremier-research.comTier 2 · Direct publisher

End-to-End Traceability: Connecting Source, Systems, and TMF

Premier ResearchOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

Inhibikase Therapeutics Announces Sale of $50 Million of Shares Through its At-the-Market (ATM) Facility

Yahoo Finance SingaporeOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

Germany Pharmaceutical Grade Polyethylene Glycol - Market Analysis, Forecast, Size, Trends and Insights

IndexBoxOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

Hemab Therapeutics Presents Sustained Sutacimig Bleed Reduction Data and Preclinical Factor VII Deficiency Results at ISTH 2026

Quiver QuantitativeOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

Recent Cancer Trial Failures and Setbacks: A Quick Look

Oncology News CentralOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

CervoMed Announces New Clinical, Plasma Biomarker and Imaging Data at AAIC 2026 for Neflamapimod in the Treatment of Dementia with Lewy Bodies (DLB)

The Manila TimesOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

Pharma Facilities Begin Gateway Rollout With Up to 4x Faster Screening

Stock TitanOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

CervoMed Reports Stable Right Basal Forebrain Volume Over 48 Weeks

Stock TitanOriginal source

🇺🇰Jul 14Researched.ac.ukTier 2 · Direct publisher

Preterm birth impacts early educational achievements

University of EdinburghOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

Agenus stock doubles as biotech narrows Phase 3 bet

thestreet.comOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

AI Biopharma Biossil Plans to Advance Experimental C. diff Drug

Stock TitanOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

Hepatitis E Has No Approved Treatments as Atea Begins Human Trial

Stock TitanOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

Can-Fite's Namodenoson in Phase 3 liver cancer study; pancreatic trial planned

Stock TitanOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

Summit Therapeutics Signs Agreement to Sell Phase III Asset Ridinilazole to Biossil, Inc.

Business WireOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

New map shows how pharmaceuticals support jobs, health and growth across every UK nation

The Association of the British Pharmaceutical Industry|ABPIOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

European biotech chases record VC funding

Yahoo! Finance CanadaOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

Enterprise value to EBITDA forward of Mycenax Biotech Inc. – TPEX:4726

TradingViewOriginal source

🇺🇰Jul 14Regulatorygov.ukTier 1 · Regulatory source

Unpaid carers action plan: recognise, refer, reach

This action plan aims to improve the lives of unpaid carers in England.

UK Department of Health and Social CareOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

Biotech infrastructure review: where investment is flowing

The Pharma LetterOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

Cathay Biotech And Unit File Trade Secret Infringement Lawsuit

TradingViewOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

Atrium's First PRKAG2 Trial to Evaluate Treatment for Disease Cause

Stock TitanOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

Hansoh Pharmaceutical : PHARMA ANNOUNCES LICENSE COLLABORATION AND STRATEGIC INVESTMENT WITH AVERE FOR ORAL IL‑23 ASSET HS‑20118

marketscreener.comOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

Shampoo, chemicals in your milk? ₹2 crore adulteration racket exposed in Maharashtra

Business TodayOriginal source

🇺🇰Jul 14Regulatorygov.ukTier 1 · Regulatory source

SaBTO reports and guidance documents

Reports published by the advisory committee on the Safety of Blood, Tissues and Organs (SaBTO).

UK Department of Health and Social CareOriginal source

🇺🇰Jul 14Regulatorygov.ukTier 1 · Regulatory source

SaBTO annual report 2024 to 2025

This report sets out the work of the Advisory Committee on the Safety of Blood, Tissues and Organs (...

UK Department of Health and Social CareOriginal source

🌍Jul 14Mediacentogene.comTier 2 · Direct publisher

CENTOGENE takes ownership in Pearl Medical Analysis Lab in Abu Dhabi

CentogeneOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

[EFFECT] Edesa Biotech, Inc. SEC Filing

Stock TitanOriginal source

🇺🇰Jul 14Researched.ac.ukTier 2 · Direct publisher

Swimmer Archie Goodburn goes from graduation to the Games

University of EdinburghOriginal source

🇺🇸Jul 14Researchpubmed.ncbi.nlm.nih.govTier 1 · Research record

Allogeneic CD70-Targeted Chimeric Antigen Receptor T-Cell Therapy for Advanced Renal Cell Carcinoma: Results From the Phase I TRAVERSE Trial

PubMed Journal of Clinical Oncology RSSOriginal source

🇺🇸Jul 14Researchpubmed.ncbi.nlm.nih.govTier 1 · Research record

Clinical and Psychological Outcomes After Monoclonal Gammopathy Screening: A Population-Based Screening Study and Subsequent Randomized Trial of Follow-Up

PubMed Journal of Clinical Oncology RSSOriginal source

🇺🇸Jul 14Researchpubmed.ncbi.nlm.nih.govTier 1 · Research record

Erratum: Phase I/II Study of Sonrotoclax (BGB-11417) Monotherapy in Patients With Mantle Cell Lymphoma Previously Treated With Anti-CD20 Therapy and a Bruton Tyrosine Kinase Inhibitor

PubMed Journal of Clinical Oncology RSSOriginal source

🇺🇸Jul 14Researchpubmed.ncbi.nlm.nih.govTier 1 · Research record

Rituximab Maintenance Added to Ibrutinib-Containing Therapy in Younger, Untreated Patients With Mantle Cell Lymphoma: Results From the TRIANGLE Trial

PubMed Journal of Clinical Oncology RSSOriginal source

🇺🇸Jul 14Researchpubmed.ncbi.nlm.nih.govTier 1 · Research record

Factor VIII Aurora: A Naturally Occurring Gain of Function FVIII Variant with Enhanced FIXa Affinity

PubMed Blood RSSOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

Spero’s $1.1B antibody deal targets two immune diseases

Stock TitanOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

Donald Trump's Drug-Pricing Deals Are Reshaping Big Pharma -- Here's What That Means for Pfizer, AbbVie, and Bristol Myers Squibb

The Motley FoolOriginal source

🌍Jul 14discoverynews.google.comTier 2 · Trade media

After $4.7B sale to Novo Nordisk, former Akero team announces new I&I company with China drug

Endpoints NewsOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

Cambridge biotech strikes $1.1B deal with Chinese partner, shifts to immunology

The Business JournalsOriginal source

🌍Jul 14discoverynews.google.comTier 2 · Trade media

Avere goes public via NextCure reverse merger, secures Hansoh IL-23 drug with $2.3B deal

Fierce BiotechOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

ARBS: Green biotech innovator with key partnerships in cosmetics and agriculture

TradingViewOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

Cathie Wood Is Loading Up on This Biotech Stock. Is It a No-Brainer Buy?

The Motley FoolOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

Elevara Medicines appoints biotech veteran as CEO

The Pharma LetterOriginal source

🌍Jul 14discoverynews.google.comTier 2 · Trade media

Novartis and Chai Discovery collaborate on antibody identification

Pharmaceutical TechnologyOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

Annexon: Perfect Complement To A Speculative Biotech Portfolio (NASDAQ:ANNX)

Seeking AlphaOriginal source

🇺🇰Jul 14Regulatorygov.ukTier 1 · Regulatory source

Travellers reminded to take precautions to avoid infections abroad this summer

Data shows cases of imported dengue and Zika virus disease continuing through spring into summer as...

UK Health Security AgencyOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

Digital process development for cell and gene therapy

News-MedicalOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

25 Transfers in 21 Years: Who is Tukaram Mundhe? IAS Officer Leading Maharashtra’s Food Safety Crackdown

Outlook IndiaOriginal source

🌍Jul 14discoverynews.google.comTier 2 · Trade media

Germany approves healthcare costs overhaul despite significant pharma opposition

Pharmaceutical TechnologyOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

Donald Trump's Drug-Pricing Deals Are Reshaping Big Pharma -- Here's What That Means for Pfizer, AbbVie, and Bristol Myers Squibb

The Globe and MailOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

Cathie Wood Is Loading Up on This Biotech Stock. Is It a No-Brainer Buy?

The Globe and MailOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

Cathie Wood Is Loading Up on This Biotech Stock. Is It a No-Brainer Buy?

Yahoo FinanceOriginal source

🇺🇰Jul 14Regulatorygov.ukTier 1 · Regulatory source

Reports of cases of TB to UK enhanced tuberculosis surveillance systems 2000 to 2025

This report shows all TB cases diagnosed in the UK including those detected at post-mortem.

UK Health Security AgencyOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

China Resources Pharmaceutical Refreshes Board With New Non-Executive Director

The Globe and MailOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

Americans for Safe and Effective Medicines Launches to Protect Patients from Illegal Mass Compounding, Counterfeit Drugs, and Misleading Marketing

MorningstarOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

ACG Metals, Rockfire Resources, Sunda Energy, CelLBxHealth, Poolbeg Pharmaceutical

Yahoo FinanceOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

Celltrion ends Europe phase 3 for Keytruda biosimilar as rules ease in Korea, US, EU - CHOSUNBIZ

ChosunbizOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

Even though there are world-class large hospitals, it is difficult to secure global competitiveness..

매일경제Original source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

Jilin Aodong Pharmaceutical Sees H1 Net Profit Up 50-70% Y/Y

TradingViewOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

Regulator eases biosimilar approval requirements, waiving some phase 3 trial data

koreabiomed.comOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

Biotech ushers in new class of personal care ingredients

Personal Care InsightsOriginal source